|
1
|
Donath MY and Shoelson SE: Type 2 diabetes
as an inflammatory disease. Nat Rev Immunol. 11:98–107. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eguchi K and Manabe I: Macrophages and
islet inflammation in type 2 diabetes. Diabetes Obes Metab. 3
(Suppl 15):S152–S158. 2013. View Article : Google Scholar
|
|
3
|
Yang CM, Shin DM and Jo EK: The role of
NLR-related protein3 inflammasome in host defense and inflammatory
diseases. Int Neurourol J. 16:2–12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Masini M, Bugliani M, Lupi R, del Guerra
S, Boggi U, Filipponi F, Marselli L, Masiello P and Marchetti P:
Autophagy in human type 2 diabetes pancreatic beta cells.
Diabetologia. 52:1083–1086. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gomes LC, Di Benedetto G and Scorrano L:
During autophagy mitochondria elongate, are spared from degradation
and sustain cell viability. Nat Cell Biol. 13:589–598. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goldman SJ, Taylor R, Zhang Y and Jin S:
Autophagy and the degradation of mitochondria. Mitochondrion.
10:309–315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee J, Giordano S and Zhang J: Autophagy,
mitochondria and oxidative stress: Cross-talk and redox signalling.
Biochem J. 441:523–540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Twig G, Elorza A, Molina AJ, Mohamed H,
Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, et al:
Fission and selective fusion govern mitochondrial segregation and
elimination by autophagy. EMBO J. 27:433–446. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tal MC, Sasai M, Lee HK, Yordy B, Shadel
GS and Lwasaki A: Absence of autophagy results in reactive oxygen
species-dependent amplification of RLR signaling. Proc Natl Acad
Sci USA. 106:2770–2775. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Petersen KF, Dufour S, Befroy D, Garcia R
and Shulman GI: Impaired mitochondrial activity in the
insulin-resistant offspring of patients with type 2 diabetes. N Eng
J Med. 350:664–671. 2004. View Article : Google Scholar
|
|
11
|
Masters SL, Dunne A, Subramanian SL, Hull
RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen
Z, et al: Activation of the Nlrp3 inflammasome by islet amyloid
polypeptide provides a mechanism for enhanced IL-1β in type 2
diabetes. Nat Immunol. 11:897–904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jing Yin J, Bo Li Y, Ming Cao M and Wang
Y: Liraglutide improves the survival of INS-1 cells by promoting
macroau-tophagy. Int J Endocrinol Metab. 11:184–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wen H, Gris D, Lei Y, Jha S, Zhang L,
Huang MT, Brickey WJ and Ting JP: Fatty acid-induced NLRP3ASC
inflammasome activation interferes with insulin signaling. Nat
Immunol. 12:408–415. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan JY, Cooney GJ, Biden TJ and Laybutt
DR: Differential regulation of adaptive and apoptotic unfolded
protein response signalling by cytokine-induced nitric oxide
production in mouse pancreatic beta cells. Diabetologia.
54:1766–1776. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cani PD, Amar J, Iglesias MA, Poggi M,
Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et
al: Metabolic endotoxemia initiates obesity and insulin resistance.
Diabetes. 56:1761–1772. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Van der Crabben SN, Blümer RM, Stegenga
ME, Ackermans MT, Endert E, Tanck MW, Serlie MJ, van der Poll T and
Sauerwein HP: Early endotoxemia increases peripheral and hepatic
insulin sensitivity in healthy humans. J Clin Endocrinol Metab.
94:463–468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi SE, Lee SM, Lee YJ, Li LJ, Lee SJ,
Lee JH, Kim Y, Jun HS, Lee KW and Kang Y: Protective role of
autophagy in palmitate-induced INS-1 beta-cell death.
Endocrinology. 150:126–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia G, Zhu T, Li X, Jin Y, Zhou J and Xiao
J: ROS-mediated autophagy through the AMPK signaling pathway
protects INS-1 cells from human islet amyloid polypeptide-induced
cytotoxicity. Mol Med Rep. 18:2744–2752. 2018.PubMed/NCBI
|
|
20
|
Ashcroft FM, Rohm M, Clark A and Brereton
MF: Is type 2 diabetes a glycogen storage disease of pancreatic β
Cells? Cell Metab. 26:17–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Böni-Schnetzler M, Thorne J, Parnaud G,
Marselli L, Ehses JA, Kerr-Conte J, Pattou F, Halban PA, Weir GC
and Donath MY: Increased interleukin (IL)-1β messenger ribonucleic
acid expression in beta-cells of individuals with type 2 diabetes
and regulation of IL-1beta in human islets by glucose and
autostimulation. J Clin Endocrinol Metab. 93:4065–4074. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maedler K, Sergeev P, Ris F, Oberholzer J,
Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA and Donath MY:
Glucose-induced beta-cell production of interleukin-1beta
contributes to glucotoxicity in human pancreatic islets. J Clin
Invest. 110:851–860. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ribaux P, Ehses JA, Lin-Marq N, Carrozzino
F, Böni-Schnetzler M, Hammar E, Irminger JC, Donath MY and Halban
PA: Induction of CXCL1 by extracellular matrix and autocrine
enhancement by interleukin-1 in rat pancreatic beta-cells.
Endocrinology. 148:5582–5590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mandrup-Poulsen T, Bendtzen K, Nerup J,
Dinarello CA, Svenson M and Nielsen JH: Affinity-purified human
interleukin I is cytotoxic to isolated islets of langerhans.
Diabetologia. 29:63–67. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Donath MY, Schumann DM, Faulenbach M,
Ellingsgaard H, Perren A and Ehses JA: Islet inflammation in Type 2
diabetes: from metabolic stress to therapy. Diabetes Care. 2 (Suppl
31):S161–S164. 2008. View Article : Google Scholar
|
|
26
|
Schroder K and Tschopp J: The
inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao G, Dharmadhikari G, Maedler K and
Meyer-Hermann M: Possible role of interleukin-1β in type 2 diabetes
onset and implications for anti-inflammatory therapy strategies.
PLoS Comput Biol. 10:e10037982014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maedler K, Schumann DM, Sauter N,
Ellingsgaard H, Bosco D, Baertschiger R, Iwakura Y, Oberholzer J,
Wollheim CB, Gauthier BR and Donath MY: Low concentration of
interleukin-1beta induces FLICE-inhibitory protein-mediated β-cell
proliferation in human pancreatic islets. Diabetes. 55:2713–2722.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Green DR, Galluzzi L and Kroemer G:
Mitochondria and the autophagy-inflammation-cell death axis in
organismal aging. Science. 333:1109–1112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh R and Cuervo AM: Autophagy in the
cellular energetic balance. Cell Metab. 13:495–504. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kroemer G and Levine B: Autophagic cell
death: The story of a misnomer. Nat Rev Mol Cell Biol. 9:1004–1010.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou R, Tardivel A, Thorens B, Choi I and
Tschopp J: Thioredoxin-in-teracting protein links oxidative stress
to inflammasome activation. Nat Immunol. 11:136–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lohitesh K, Saini H, Srivastava A,
Mukherjee S, Roy A and Chowdhury R: Autophagy inhibition
potentiates SAHA-mediated apoptosis in glioblastoma cells by
accumulation of damaged mitochondria. Oncol Rep. 39:2787–2796.
2018.PubMed/NCBI
|
